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Abstract
Introduction: Factors explaining the greater susceptibility of preterm infants to severe lower respiratory infections
with respiratory syncytial virus (RSV) remain poorly understood. Fetal/newborn lambs are increasingly appreciated
as a model to study key elements of RSV infection in newborn infants due to similarities in lung alveolar
development, immune response, and susceptibility to RSV. Previously, our laboratory demonstrated that preterm
lambs had elevated viral antigen and developed more severe lesions compared to full-term lambs at seven days
post-infection. Here, we compared the pathogenesis and immunological response to RSV infection in lungs of
preterm and full-term lambs.
Methods: Lambs were delivered preterm by Caesarian section or full-term by natural birth, then inoculated with
bovine RSV (bRSV) via the intratracheal route. Seven days post-infection, lungs were collected for evaluation of
cytokine production, histopathology and cellular infiltration.
Results: Compared to full-term lambs, lungs of preterm lambs had a heightened pro-inflammatory response after
infection, with significantly increased MCP-1, MIP-1a, IFN-g, TNF-a and PD-L1 mRNA. RSV infection in the preterm
lung was characterized by increased epithelial thickening and periodic acid-Schiff staining, indicative of glycogen
retention. Nitric oxide levels were decreased in lungs of infected preterm lambs compared to full-term lambs,
indicating alternative macrophage activation. Although infection induced significant neutrophil recruitment into the
lungs of preterm lambs, neutrophils produced less myeloperoxidase than those of full-term lambs, suggesting
decreased functional activation.
Conclusions: Taken together, our data suggest that increased RSV load and inadequate immune response may
contribute to the enhanced disease severity observed in the lungs of preterm lambs.
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Introduction
Respiratory syncytial virus (RSV) is the most common
cause of severe lower respiratory tract disease in chil-
dren, with the highest morbidity occurring in the young-
est infants [1-3]. Preterm infants are particularly
susceptible to the disease, due in part, to their immature
immune system, low birth weight, and lung immaturity.
Recent literature suggests that infants born 33-35 weeks
of gestation are at similar risk for RSV-related lower
respiratory tract infection as infants born less than 32
weeks of gestation (reviewed in [4]). RSV-related hospi-
talization rates of infants born at 33-35 weeks of gesta-
tion are twice as high as those of term infants [5].
Currently, there is no RSV vaccine, and the only preven-
tive treatment for the disease involves passive immuni-
zation with antibody against RSV [3,6].
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stood; however, a multifactorial process that includes
virus-induced pathology and a concomitant exaggerated
host immune response may play critical roles in the dis-
ease process [7,8]. Increased viral load is thought to
contribute to the severity of disease [9], although the
underlying mechanisms responsible for increased viral
replication in some individuals are not completely
understood. RSV specific immunity is also believed to
be involved in the mechanism of severe lower respira-
tory tract disease, based on experiences with a formalin-
inactivated RSV vaccine preparation during which vacci-
nated infants developed an enhanced eosinophilia to re-
infection [10,11].
Previously, our laboratory has shown that preterm
lambs infected with bovine RSV (bRSV) developed clini-
cal symptoms and lesions that paralleled the course of
disease observed in human infants suffering from severe
RSV disease [12]. Moreover, they had a reduced capacity
for RSV antigen clearance compared to full-term lambs
[12]. The precise mechanisms underlying the age-depen-
dent disease severity and the lack of RSV clearance were
not investigated. Therefore, we studied the relationship
between developmental age and immunological compe-
tence in response to RSV infection by assessing for dif-
ferences in the nature of the inflammatory response in
the lungs of preterm and full-term lambs. We hypothe-
sized that the increased viral load in preterm lambs is
associated with an altered distribution and functional
activation of immune cells and increased lung pathology
that differs from full-term lambs.
Materials and methods
Animals
Animal use and experimental procedures were
approved by Iowa State University’sA n i m a lC a r ea n d
Use Committee. We used banked lung samples from
lambs that were used in another study to characterize
bRSV infection in the lamb model [12]. Briefly, lambs
were delivered preterm by Caesarian section at 138
days of gestation (term is 147 days) or full-term by
natural birth. Both groups were inoculated with bRSV
strain 375 (20 ml at 10
3-4 TCID50/ml) or sterile cell
growth media (20 ml) via the intratracheal route.
Lambs (n = 6 for the preterm control group, n = 6
preterm RSV, n = 3 full-term control, n = 5 full-term
RSV) were euthanized with sodium pentobarbital i.v.
7 days post-infection. Sections of the right middle
lung lobe were removed, snap-frozen in liquid nitro-
gen and stored at -80°C for real-time RT-PCR and
other functional assays. Additional sections of the
right cranial lung lobe were fixed in 10% neutral-buf-
fered formalin for histopathology and immunohisto-
chemical analyses.
Histopathology, lesions and staining scores
After formalin fixation, lung samples were embedded in
paraffin blocks. Lung sections (5 μm) were stained with
H&E to assess histologic changes, including cellular
infiltration and epithelial alterations. Cellular infiltration
and epithelial hyperplasia were described and scored by
a pathologist (MRA) using a minimum of three 20X
fields in each lung section.
The extent of neutrophil infiltration in bronchioles
and alveoli surrounding affected bronchioles in the 20X
fields were scored with the following scale: 0 = no sig-
nificant neutrophil infiltration, 1 = detectable presence
of 1 to 5 neutrophils within bronchioles/alveolar lumens
in 20X field, 2 = groups (greater than 5) of cells in
bronchioles/alveolar lumens in 20X field, 3 = accumula-
tion of cells that fills bronchioles/alveolar lumens in
20X field, 4 = dense infiltration of cells that distends
bronchiolar and alveolar lumens in a 20X field. Macro-
phage infiltration was determined using the same scor-
ing system.
Lymphocytes and plasma cell infiltration into the
alveolar and bronchiolar institium were scored with the
following scale of 20X fields: 0 = no significant infiltra-
tion, 1 = presence of infiltrating cells in alveolar septa
or bronchiolar interstitium, 2 = accumulation of several
cells within alveolar septa or bronchiolar interstitium, 3
= accumulation of cells that expands the alveolar septa
or bronchiolar interstitium, 4 = accumulation of cells
that forms dense aggregates in the alveolar septum or
bronchiolar interstitium.
With delivery of RSV inoculum in this study, lesions
were present within distal bronchioles and alveoli [12].
In contrast, bronchi and large proximal bronchioles lack
lesions and RSV antigen. Thus only distal bronchioles
were scored for epithelial alterations and these airways
were relatively uniform in size and diameter. Bronchio-
lar epithelial hyperplasia was scored with the following
scale: 0 = no lesion, 1 = first detectable thickening
resulting in mild hypertrophy of bronchiolar cells and
occasional cells more than one layer thick, 2 = thicken-
ing that is double the normal thickness of a single
cuboidal cell, 3 = thickening that protrudes into and
partially occludes the airway lumen and slight expan-
sion/distension of the airway, 4 = thickening that
occludes the airway lumen resulting in a very narrow
(slit) lumen and marked distension of the airway.
Lung sections were also stained with periodic acid-
Schiff (PAS) to assess the stage of epithelial differentia-
tion/maturity as a measure of glycogen retention in type
II pneumocytes. The thickened epithelial layers had vari-
able levels of staining avidity, and ten alveoli were
scored per lung section from each lamb. Alveoli were
similar in size which ranged between 100-200 μmi n
diameter. Scoring was based on predetermined scale: 0,
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plasmic staining present in less than 30% of alveolar
epithelial cells; 3, cytoplasmic staining present in more
than 60% of alveolar epithelial cells.
RNA isolation and one-step real-time reverse
transcriptase qPCR
Total RNA was isolated from lung tissue as previously
described [13] using a procedure based on TRIzol
reagent (Invitrogen, Carlsbad, CA). The RNA samples
were DNase-treated using TURBO DNase (TURBO
DNA-free kit, Ambion, Austin, TX). RNA concentra-
tions and purity were measured by absorbance readings
at 260 nm and 280 nm.
Initial RT-qPCR analysis involved running a test plate
for each target to identify the best RNA dilution ranges
in which PCR inhibition was not observed, and where
amplification efficiencies were better than 80%. Test-
plate set-up parameters and analysis were performed
using PREXCEL-Q [14]. RNA samples were used at
0.784 ng/μl in fluorogenic one-step real-time qPCR
reactions. Each 20 μl reaction contained 4.8 μlo fR N A
sample, 775 nM primers, 150 nM TaqMan hydrolysis
probe (5’-6FAM, 3’-TAMRA-quenched or 5’-6FAM, 3’-
MGBNFQ), nuclease-free water, 5.5 mM MgSO4, Super-
Script III RT/Platinum Taq mix (Invitrogen), and One-
step reaction mix with ROX (Invitrogen). Primers and
probes sequences for all targets except perforin can be
found in [13,15]. Sequences for perforin are: Fwd: 5’-GC
CGTGAGTAAGTATGTGACTGACA; Rev: 5’-GCCAG
GACACATGCATTGG; Probe: 6FAM-TGGAGGG
ACTGCAACC-MGBNFQ). The samples were placed in
duplicate wells of 96-well plates (Eppendorf, Westbury,
NY). No-template control (NTC) and no-reverse tran-
scriptase (NRC) reactions consistently demonstrated
lack of target contamination and negligible genomic
DNA contamination. The GeneAmp 5700 Sequence
Detection System (Applied Biosystems) was pro-
grammed for thermocycling at 15 min 55°C, 2 min 95°
C, and 50 cycles of 15 s 95°C, 30 s 58°C. Quantification
cycle (Cq) values generated by the GeneAmp 5700 sys-
tem were further assessed using custom Excel files
employing the efficiency-corrected standard curve-based
relative quantification (Pfaffl) approach for qPCR [16].
R e s u l t sa r ee x p r e s s e da sg e n e( m R N A )e x p r e s s i o no f
infected samples relative to that of uninfected samples.
Immunohistochemistry (IHC) and scoring system for
myeloperoxidase and caspase 3
Sections were made from paraffin-embedded blocks on
the same day and were stained for either myeloperoxi-
dase or caspase 3 in a single batch for uniformity.
Briefly, paraffin-embedded lung sections were deparaffi-
nized, blocked in 10% normal goat serum + 10% normal
swine serum in PBS, then stained with 1:300 rabbit anti-
human myeloperoxidase (Dako, Carpinteria, CA) or
1:1000 rabbit anti-human/mouse active caspase 3 (R&D
Systems, Minneapolis, MN) followed by 1:300 biotiny-
lated goat anti-rabbit IgG (Kirkegaard & Perry Labora-
tories, Gaithersburg, MD), streptavidin-conjugated
horseradish peroxidase (BioGenex) and Nova Red (Vec-
tor, Burlingame, CA). Finally, the slides were counter-
stained with Harris’ hematoxylin. Scoring for
myeloperoxidase (MPO) were made in 40 × sections
from at least 3 fields per lung lobe per animal where 0
= no staining, 1 = 1-10% of neutrophils had MPO
immunoreactivity (IR; MPO-IR), 2 = 11-30% of neutro-
phils had MPO-IR; 3 = 30-60% of neutrophils had
MPO-IR and 4 = > 60% of neutrophils had MPO-IR.
Scores for caspase 3 IR ranged from 0-4 and were
assigned to bronchiolar and alveolar areas. In bronch-
ioles: (0 = no staining, 1 = 1-10%, 2 = 11-30%, 3 = 30-
60%, 4 = more than 60% of airway epithelia had immu-
noreactivity to caspase 3). In alveoli, staining occurred
in consolidated areas, containing lymphocytes, plasma
cells, macrophages and alveolar epithelia: (0 = no stain-
ing, 1 = 1-10%, 2 = 11-30%, 3 = 30-60%, 4 = more than
60% of consolidated areas had immunoreactivity to cas-
pase 3).
Lung nitrite levels
Lungs were homogenized in a Tissue Protein Extraction
Reagent (T-PER; Fisher Science, Hanover Park, IL) at a
ratio of 1 g tissue/20 ml T-PER. After the addition of
protease inhibitors cocktail tablets (Roche), the samples
were homogenized using an Omni TH homogenizer
(Omni International). Protein concentration was deter-
mined using the Coomassie Plus Protein Assay Reagent
(Fisher). Nitrite levels in lung homogenates were mea-
sured using a commercially available Griess reaction
assay kit as per the manufacturer’s instructions (Pro-
mega, Madison, WI). The optical density at 550 nm
(OD550) was measured using a microplate reader. Nitrite
concentrations were calculated by comparison with the
OD550 of standard solutions of sodium nitrite.
Lung arginase activity
Arginase levels in lung homogenates were measured
using a commercially available assay (QuantiChrom
arginase assay kit by BioAssay System, Hayward, CA).
Methods followed the manufacturer’s recommendations.
Arginase activity (units/L) in all lung samples was calcu-
lated by comparison with the OD520 of standard solu-
tion of urea.
Statistical analysis
The results were analyzed by one-way ANOVA using
SAS version 9.1 (SAS Institute, Cary, NC). Mean values
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and RSV-infected animals were compared at *p < 0.05,
**p < 0.01, and ***p < 0.001 and expressed as means ±
SE.
Results
RSV infection induces higher relative mRNA levels of
innate immune mediators in preterm lambs than full-term
lambs
Previously, our laboratory demonstrated that the bRSV
challenge dose used to infect lambs caused clinical
signs and pulmonary lesions typical of severe human
RSV disease [12]. Moreover, we reported that preterm
lambs had enhanced viral load in their lungs compared
to full-term lambs [12]. In order to compare the
immune response during RSV infection across age
groups in lambs, we measured the expression of sev-
eral key innate immunity mediators at the mRNA
level. Levels of MIP-1a,M C P - 1 ,I L - 8 ,T N F - a,I F N - g
and IL-10 (Figure 1A-F) were significantly increased in
RSV-infected animals compared to control animals of
the same age group. Full-term lambs infected with
RSV had statistically signifi c a n te n h a n c e de x p r e s s i o no f
MIP-1a,M C P - 1 ,I L - 8a n dI F N - g,b u tn os i g n i f i c a n t
changes in the expression of TNF-a and IL-10 when
compared to control animals of the same age group.
Comparisons across age groups following infection
revealed that expression of MIP-1a,M C P - 1 ,I L - 1 0 ,
TNF-a and IFN-g were significantly increased by infec-
tion in preterm lambs compared to full-term lambs.
These results suggest that an inadequately enhanced
immune response occurs in the lungs of preterm
lambs after RSV infection.
RSV infection is associated with airway structural changes
and increased caspase 3 staining in preterm lambs
During infection, epithelial cell injury occurs and is
associated with proliferation of nearby epithelia to
replace injured cells (epithelial cell thickening/hyperpla-
sia). Consistent with this, we determined that control
lambs of either age group lacked lesions and areas of
epithelial hyperplasia at 7 days post-inoculation with
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Figure 1 RSV infection induces higher levels of innate immune mediators in preterm lambs than full-term lambs. mRNA levels were
measured by qPCR and expressed as fold induction relative to control animals at the same time point. Preliminary correlation analysis of qPCR
data determined that the level of each mediator was similar between control animals of either age groups. (A) MIP-1a, (B) MCP-1, (C) IL-8, (D)
TNF-a, (E) IFN-g and (F) IL-10. The data represent the mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001 by ANOVA. NS, p > 0.05.
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degrees of thickening of the epithelial lining were pre-
sent in multifocal bronchioles of preterm (long arrows
in Figure 2A), and to a lesser degree, full-term lambs
(Figure 2B). This was due to hyperplasia of the
bronchiolar epithelium with the presence of occasional
mitotic figures (short arrow; Figure 2A) and formation
of occasional syncytial cells (data not shown). The
epithelial cells were cuboidal to polygonal and formed
one to several layers in thickness. Epithelial cells in the
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Figure 2 RSV infection is associated with airway structural changes in the preterm lung. (A) Representative H&E stain of lung sections
from control preterm lamb and RSV-infected preterm lamb. Long arrows represent epithelial thickening, and the short arrow represents a
mitotic figure. Bars = 200 μm. (B) Lung sections from each animal were stained with H&E, and epithelial thickening (epithelial cell proliferation/
hyperplasia) was scored (see materials and methods section for scoring system). (C) Representative Periodic Acid Schiff (PAS) stain of lung
sections from preterm and full-term lambs comparing control to RSV-infected groups. Lung sections were examined under a 20X field. Bars =
200 μm. The data represent the mean ± SE. *p < 0.05 by ANOVA. NS, p > 0.05.
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with intense staining for PAS (Figure 2C), indicating
increased glycogen retention and cellular immaturity.
Lungs of RSV-infected preterm lambs had significantly
more PAS
+ cells than those of RSV-infected full-term
lambs (Figure 2C). However, a decrease in epithelial
PAS staining was observed during maturation of lung,
independent of infection (Figure 2C). This finding,
which is consistent with published data comparing the
distribution of PAS
+ cells through ontogeny in the ovine
lung [17], suggests that preterm birth and RSV infection
m a yb ei n d e p e n d e n tf a c t o r st h a tc o n t r i b u t et ot h e
increased epithelial glycogen retention.
In addition to the epithelial hyperplasia, pulmonary
microscopic lesions were present in RSV-infected ani-
mals (Figure 3A). These lesions were similar in both
preterm and full-term lambs, but were often accentuated
in the preterm lambs. Briefly, multifocal bronchioles of
all lambs contained variable infiltrates of neutrophils,
occasional degenerate epithelial cells and cell debris
with occasional macrophages. Alveolar lumens around
these bronchioles had increased numbers of alveolar
macrophages with cell debris and small amounts of ser-
oproteinaceous fluid. Infiltrates of lymphocytes and
plasma cells were present in alveolar septa and around
bronchioles in the bronchiolar adventitia and, to a lesser
degree, in the bronchiolar lamina propria (Figure 3A).
The observed lung pathology is consistent with RSV
infection and has been similarly described in RSV-
infected humans [18], cattle (reviewed in [19]) and
lambs [12,20-22].
To assess the apoptotic response, lung caspase 3 expres-
sion was detected by immunohistochemistry (IHC). Cas-
pase 3 immunoreactivity (IR) was seen in alveolar areas of
both groups of infected lambs. However, alveoli of RSV-
infected preterm lambs had significantly enhanced IR to
caspase 3 when compared to full-term lambs (Figure 3B).
A similar trend and level of caspase 3 IR was also observed
in bronchioles of infected lambs (Figure 3C). The
enhanced viral load observed in lungs of preterm lambs
may contribute to the pro-apoptotic response observed.
Neutrophils of RSV-infected preterm lambs have reduced
myeloperoxidase levels compared to full-term lambs
The primary RSV infection in infants is characterized by
a strong neutrophil influx into the airways [23-25].
Increased numbers of neutrophils were also detected in
lungs of preterm and full-term RSV-infected lambs com-
pared to control lambs (Figure 4A). We also assessed the
levels of myeloperoxidase, a key constituent of neutro-
phils cytotoxic armament [26], by IHC in lung sections.
RSV infection was associated with myeloperoxidase IR in
both preterm (Figure 4B) and full-term (Figure 4C)
lambs when compared to control lambs of the same age
groups. However, comparisons across age groups
revealed that myeloperoxidase IR was significantly
reduced in preterm lambs infected with RSV compared
to full-term lambs infected with RSV (Figure 4D). MPO
levels in control lambs of either age group were minimal
to non-detectable because there were few neutrophils in
lung sections from those animals. As neutrophils from
myeloperoxidase-deficient individuals kill microorgan-
isms poorly [27,28], our results suggest that neutrophils
from RSV-infected preterm lambs may have reduced
functionality compared to RSV-infected full-term lambs.
Macrophages from preterm lambs are recruited to the
lung after infection, but produce less nitric oxide than
infected full-term lambs
Because preterm lambs have increased viral loads in the
lung [12], we hypothesized that antigen presenting cells,
in particular macrophages, were not effectively recruited
to the lungs. However, histological analysis of lung sec-
tions from preterm lambs in this study indicated that
macrophage infiltration was significantly increased by
infection when compared to uninfected animals (Figure
5A). In full-term lambs the differences in macrophage
numbers between control and infected lungs were not
statistically significant (Figure 5A). These findings sug-
gest that the inability of preterm lambs to clear virus
from their lungs was not dependent on macrophage
numbers.
Since macrophage numbers were similar between pre-
term and full-term lambs, we reasoned that the func-
tional activity of macrophages of preterm lambs might
differ. Whereas the generation of nitric oxide is a hall-
mark of classically activated macrophages, the pheno-
type of alternatively activated macrophages includes
induction of arginase 1 and reduced levels of nitrate
(reviewed in [29]). We measured levels of nitrite, a
stable breakdown product of nitric oxide, and arginase
in lung homogenates from both groups of lambs. While
full-term animals displayed an increase in nitrite levels
in their lungs following infection, those of preterm ani-
mals were significantly reduced by infection (Figure 5B).
No significant changes in arginase levels were measured
in either group of lambs regardless of RSV infection
(Figure 5C). These findings suggest that macrophages
are recruited following RSV infection, but have an
altered functional state in the preterm lung.
Lungs from infected preterm lambs display similar trends
in lymphocytic infiltration and functional state compared
to full-term lambs
Scoring for lymphocytes and plasma cell infiltration
revealed that RSV infection induced comparable cellular
recruitment in the lung in both preterm and full-term
lambs (Figure 6A). The functional state of the
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Figure 3 RSV infection is associated with lung pathology and enhanced caspase 3 staining in the preterm lung. (A) Representative
Haematoxylin and Eosin (H&E) stain of lung sections from preterm and full-term lambs comparing control to RSV-infected groups. Lung sections
were examined under a 20X field. Bars = 200 μm. Immunoreactivity (IR) to caspase 3 in alveoli (B) and bronchioles (C) was scored in lungs of
control and RSV-infected animals. The data represent the mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001 by ANOVA.
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Page 7 of 12lymphocytes was assessed through perforin mRNA (Fig-
ure 6B), whose levels were induced by RSV. Similar to
the cellular infiltration, perforin mRNA was induced at
comparable levels regardless of the age of the infected
animal (Figure 6B). The expression of PD-L1, a negative
regulator of T cell function was also measured: RSV
infection significantly induced PD-L1 mRNA expression
in both groups of lambs. However, a comparison
between age groups showed that PD-L1 levels in RSV-
infected preterm lambs were significantly higher than in
RSV-infected full-term lambs (Figure 6C). Taken
together, these results suggest that lymphocytic function
may be further reduced in preterm lambs than full-term
lambs.
Discussion
Given that infants born prematurely are at higher risks
of severe lower respiratory infections with RSV [30,31],
we sought to identify potential factors responsible for
the age-dependent susceptibility to this pathogen. In
this study, we extended characterization of our preterm
lamb RSV-infection model [12] by more thoroughly
evaluating the immunological aspects of the disease.
Herein, we have provided data indicating that during
RSV infection, preterm lambs have a heightened innate
immune response associated with significant airway
structural changes and defects in the distribution and
activation of immune cells crucial to host defense
against RSV. These responses were less pronounced in
full-term lambs. The inappropriate immune response
observed in preterm lambs could be attributed to the
enhanced viral load in the lungs or to the role for devel-
opmental age in mounting an appropriate anti-RSV
response. Correlation analysis of the qPCR data showed
that the expression of all targets assessed in this study
did not differ in lungs of either uninfected preterm and
full-term lambs (data not shown).
The recognition of RSV by pathogen-associated mole-
c u l a rp a t t e r n sb yP R R ss u c ha sT L R sa n dR I G - 1[ 3 2 ]
results in a cascade of signaling events mediated by NF-
A.
B. C.
0
0.5
1
1.5
2
2.5
3
3.5
pre-term full-term
N
e
u
t
r
o
p
h
i
l
s
 
i
n
f
i
l
t
r
a
t
i
o
n
 
s
c
o
r
e
s
control
RSV
D.
0
0.5
1
1.5
2
2.5
3
3.5
pre-term full-term
M
y
e
l
o
p
e
r
o
x
i
d
a
s
e
 
I
R
 
s
c
o
r
e
s control
RSV ***
***
**
**
NS
NS
Figure 4 Neutrophils of RSV-infected preterm lambs have reduced myeloperoxidase levels compared to full-term lambs. (A) Scoring of
neutrophil infiltration in the lung sections of each animal. Histochemical analysis of myeloperoxidase expression in lungs of (B) RSV-infected
preterm lambs and (C) RSV-infected full-term lambs. (D) Scores were assigned in lungs of control and RSV-infected animals based on IR to
myeloperoxidase. The data represent the mean ± SE. **p < 0.01, ***p < 0.001 by ANOVA. NS, p > 0.05. Bars = 100 μm.
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the lung but are differentially activated after infection. (A)
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animal. (B) Nitrite levels were measured in whole lung homogenates
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Figure 6 Lungs from infected preterm lambs display similar
trends in lymphocytic infiltration compared to full-term lambs.
(A) Scoring of lymphocytes and plasma cells infiltration in the lung
sections of each animal. (B) Perforin mRNA levels were measured by
qPCR and expressed as fold induction relative to control animals of
the same time point. (C) PD-L1 mRNA levels were measured by
qPCR and expressed as fold induction relative to control animals of
the same time point. For qPCR results, preliminary correlation
analysis of qPCR data determined that the level of each mediator
was similar between control animals of either age groups. The data
represent the mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001 by
ANOVA. NS, p > 0.05.
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lead to the expression of cytokines and chemokines,
which mediate pro-inflammatory functions to recruit
and activate cells, but also regulate the pro-inflamma-
tory state (reviewed in [33,34]). In the current study,
RSV-infected preterm lambs had a heightened pro-
inflammatory response in their lungs compared to full-
term lambs. The observed heightened levels of MIP-1a,
MCP-1, IFN-g,T N F - a and IL-10 in RSV-infected pre-
term lambs may be due to the increased viral load
observed in that group of animals, or to age-related
inappropriate transcriptional regulation that contributes
to increased pathology, reduced viral clearance, and
enhanced disease severity.
RSV predominantly infects airway epithelial cells, which
form the first line of defense against the virus and are the
site of disease-associated inflammation. RSV infection of
preterm lambs was associated with changes in the bronch-
iolar epithelium, characterized by significant epithelial
thickening and increased presence of PAS staining in
epithelial cells. At present, it is unclear whether the epithe-
lial thickening and the increased PAS staining detected in
the preterm lambs are due to increased RSV replication,
to enhanced levels of immune mediators in the lambs, or a
combination of both. It is likely that the epithelial thicken-
ing, the intra-airway inflammation and bronchoconstric-
tion due to inflammation partially obstruct the
bronchiolar lumen and impairs airflow in the preterm
lung. Such changes would contribute to impaired gaseous
exchange. Additional studies on physiological measure-
ments of airflow and gas exchange would provide impor-
tant information on the disease process.
Cellular mediators of inflammation, including neutro-
phils, macrophages, T cells, B cells and eosinophils play
key roles in RSV disease in humans (reviewed in [35]).
Our findings suggest that these mediators are also
involved in the immune response triggered by RSV in
lambs. Primary RSV infection in infants is characterized
by a strong neutrophil influx [23-25]. In lambs, the neu-
trophil influx in the airways suggests that these cells
might be important contributors to RSV disease.
Reports in the literature describing the neutrophil
defense system in humans at birth have determined that
the neutrophil response is immature and functionally
suboptimal [36,37]. Our current study is consistent with
these reports in that, despite similar neutrophil infiltra-
tion at the site of infection, neutrophils from preterm
lambs had significantly lower myeloperoxidase levels
than full-term lambs following RSV infection. In addi-
tion, the ratio of myeloperoxidase IR to neutrophil infil-
tration scores (0.56 in preterm lambs, compared to 2.7
in full-term lambs) suggests that the levels of myeloper-
oxidase per neutrophil is greater in the full-term lambs..
In accordance with our findings, myeloperoxidase levels
are significantly reduced in infants born prematurely,
but not in term neonates (reviewed in [38]). In addition
to prematurity, it is likely that the inappropriate
immune response, concomitant with the enhanced viral
load in the lung, play a role in modulating myeloperoxi-
dase levels in neutrophils in preterm lambs. To our
knowledge, this is the first study to report the role of
RSV infection on myeloperoxidase levels during primary
infection in preterm lambs.
Although macrophages were recruited to the lungs of
both preterm and full-term lambs following RSV infec-
tion, the decreased nitrite levels and the trend towards
increased arginase activity in lungs of infected preterm
lambs suggest that macrophages are either immature or
differentially activated in the preterm lung infected with
RSV. Alternatively activated macrophages also fail to
produce nitric oxide through the induction of arginase
and are unable to efficiently kill intracellular pathogens
(reviewed in [39]). Based on nitrite levels and arginase
activity, our data indicates that macrophages in the
RSV-infected preterm lung may have a sub-optimal acti-
vation state, resulting in an ineffective immune response
to viral infection and poor viral clearance. In addition,
our finding that RSV-infected preterm lambs have
enhanced caspase 3 IR is in agreement with a study of
infants’ lungs with fatal lower respiratory tract illness
caused by RSV [40]. In the preterm lung, these apopto-
tic cells are probably not cleared by the macrophages,
thus contributing to an inappropriate immune response
for viral clearance.
RSV infection can dysregulate RSV-specific cytolytic T
cells expression and suppress memory development in
the respiratory tract. A rapid loss of RSV-specific mem-
ory CD8
+ cells in the lungs after infection has been
noted in mice (reviewed in [41]). In addition, RSV has
been reported to inhibit the development of cytotoxic
responses in vivo, by suppressing CD4 lymphocyte func-
tion [42], interfering with antigen-dependent T cell
receptor signaling [43], or inducing lymphocyte apopto-
sis [44] among other mechanisms. Although we
observed no significant differences in lymphocytic infil-
tration or in the expression levels of components of the
lymphocyte lytic machinery (perforin/granzyme) in this
study, RSV infection significantly induced the expression
levels of PD-1 (data not shown) and PD-L1 in the ovine
lung. Because the PD-1/PD-L1 pathway plays an impor-
tant role in regulating T cell exhaustion [45-48], it is
conceivable that other functional aspects of CD8
+ cells,
such as their capacity to degranulate, are impaired in
the RSV-infected ovine lung.
There appears to be a correlation between degrees of
cellular infiltration and chemokine levels between pre-
term and full-term lambs. Similar levels of neutrophils
are present in the infected lungs of both preterm and
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IL-8 in the two groups of infected lambs. In the absence
of infection, lungs of lambs of either age group have lit-
tle to no macrophage infiltration. However, in response
to RSV infection, the relative increase above baseline in
lung macrophage numbers appears to be higher in pre-
term lambs (infiltration scores of 0 to 2.17 in preterm
lambs compared to infiltration scores of 0.67 to 1.6 in
full-term-lambs). This is consistent with overall higher
levels of MCP-1 and MIP-1a following infection in pre-
term lungs and a relatively greater elevation in these
mediators compared with uninfected baseline levels (for
MCP-1: 4.88-fold increase in preterm compared to 3.26-
fold in full-term; for MIP-1a: 9.4-fold increase in pre-
term compared to 2.7-fold in full-term). These observa-
tions suggest that a heightened immune response to
RSV infection may occur in preterm lambs to compen-
sate for an initial deficit in baseline levels in the imma-
ture non-infected lung. This initial deficit, together with
the increased viral load, the overall exaggerated response
and altered activation state of the cells may contribute
to the increased pathology observed.
Conclusions
In summary, the current study demonstrated that RSV
infection of preterm lambs resulted in enhanced levels
of pro-inflammatory mediators, including cytokines
and chemokines. Lungs of RSV-infected preterm
lambs, but not full-term lambs, had marked structural
changes, as evidenced by epithelial thickening,
increased PAS staining and increased caspase 3 stain-
ing in bronchioles and alveoli. Although the expression
of caspase 3 suggests the activation of the apoptotic
machinery as a result of viral infection of cells, the
inefficient innate immune responses mediated in part
by the phenotypically altered neutrophils and macro-
phages likely contribute to the enhanced disease
pathology and severity. The similarities in the severity
of RSV between lambs and humans in regards to viral
susceptibility, clinical responses, lesions and immune
responses highlight the utility of the pre-term lamb
model to study pathogenesis of RSV. In addition, the
ability to induce premature birth in lambs provides an
excellent opportunity to study the mechanisms under-
lying the age-dependent susceptibility of human infants
to RSV. Finally, the outbred nature of lambs is a useful
characteristic to determine the genetic basis for sus-
ceptibility to, and re-infections with RSV.
Abbreviations used in this paper
IFN: interferon; IHC: immunohistochemistry; IL-: interleukin; IR:
immunoreactivity; MCP: monocyte chemotactic protein (also called CCL2);
MIP1-α (also called CCL3); PD-L1: programmed death ligand 1; RT-qPCR:
reverse transcriptase quantitative polymerase chain reaction; RSV: respiratory
syncytial virus; TNF-α: tumor necrosis factor α.
Acknowledgements
We thank the histology lab (Toni Christofferson, Jenny Groeltz-Thrush and
Diane Gerjets) for technical support. This research was supported in part by
NIH RO1 062787A.
Author details
1Department of Veterinary Pathology, College of Veterinary Medicine, Iowa
State University, Ames, IA 50011, USA.
2MedImmune, LLC, One MedImmune
Way, Gaithersburg, MD 20878, USA.
Authors’ contributions
FBS designed, performed the immunological experiments and data analysis
for this study, and wrote the manuscript. JMG assisted in the design,
performance and analysis of the real-time RT-PCR experiments and edited
the manuscript. SK, ACP, and JS provided intellectual input and editorial
assistance for the study, participated in the writing and editing of the
manuscript, and provided funding for the project. MRA was the principal
investigator who oversaw the project, performed the necropsy/tissue
collection/lung tissue scoring, participated in the writing and editing of the
manuscript, and provided intellectual input and funding for the project. All
authors read and approved the final manuscript.
Competing interests
This work was supported in part by MedImmune, LLC. SK, ACP and JS are
employees of MedImmune, LLC. FBS is supported by MedImmune, LLC.
Received: 11 April 2011 Accepted: 9 August 2011
Published: 9 August 2011
References
1. Hall CB: Respiratory syncytial virus. 4 edition. Philadelphia: Saunders; 1998.
2. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ,
O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E,
Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C,
Simoes EA, Rudan I, Weber MW, Campbell H: Global burden of acute
lower respiratory infections due to respiratory syncytial virus in young
children: a systematic review and meta-analysis. Lancet 2010,
375(9725):1545-1555.
3. Groothuis JR, Hoopes JM, Jessie VG: Prevention of serious respiratory
syncytial virus-related illness. I: Disease pathogenesis and early attempts
at prevention. Adv Ther 2011, 28(2):91-109.
4. Carbonell-Estrany X, Bont L, Doering G, Gouyon JB, Lanari M: Clinical
relevance of prevention of respiratory syncytial virus lower respiratory
tract infection in preterm infants born between 33 and 35 weeks
gestational age. Eur J Clin Microbiol Infect Dis 2008, 27(10):891-899.
5. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR: Rates of
hospitalization for respiratory syncytial virus infection among children in
medicaid. J Pediatr 2000, 137(6):865-870.
6. Groothuis JR, Hoopes JM, Hemming VG: Prevention of serious respiratory
syncytial virus-related illness. II: Immunoprophylaxis. Adv Ther 2011,
28(2):110-125.
7. Varga SM, Braciale TJ: RSV-induced immunopathology: dynamic interplay
between the virus and host immune response. Virology 2002, 295(2):203-207.
8. Durbin JE, Durbin RK: Respiratory syncytial virus-induced immunoprotection
and immunopathology. Viral Immunol 2004, 17(3):370-380.
9. DeVincenzo JP, El Saleeby CM, Bush AJ: Respiratory syncytial virus load
predicts disease severity in previously healthy infants. J Infect Dis 2005,
191(11):1861-1868.
10. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH:
Respiratory syncytial virus disease in infants despite prior administration
of antigenic inactivated vaccine. Am J Epidemiol 1969, 89(4):422-434.
11. Kim HW, Leikin SL, Arrobio J, Brandt CD, Chanock RM, Parrott RH: Cell-
mediated immunity to respiratory syncytial virus induced by inactivated
vaccine or by infection. Pediatr Res 1976, 10(1):75-78.
12. Meyerholz DK, Grubor B, Fach SJ, Sacco RE, Lehmkuhl HD, Gallup JM,
Ackermann MR: Reduced clearance of respiratory syncytial virus infection
in a preterm lamb model. Microbes Infect 2004, 6(14):1312-1319.
Sow et al. Respiratory Research 2011, 12:106
http://respiratory-research.com/content/12/1/106
Page 11 of 1213. Sow FB, Gallup JM, Meyerholz DK, Ackermann MR: Gene profiling studies
in the neonatal ovine lung show enhancing effects of VEGF on the
immune response. Dev Comp Immunol 2009, 33(6):761-771.
14. Gallup JM, Ackermann MR: The ‘PREXCEL-Q Method’ for qPCR. Int J
Biomed Sci 2008, 4(4):273-293.
15. Sow FB, Gallup JM, Olivier A, Krishnan S, Patera AC, Suzich J,
Ackermann MR: Respiratory syncytial virus is associated with an
inflammatory response in lungs and architectural remodeling of lung-
draining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol
Physiol 2011, 300(1):L12-24.
16. Pfaffl MW: A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
17. Meyerholz DK, DeGraaff JA, Gallup JM, Olivier AK, Ackermann MR: Depletion
of alveolar glycogen corresponds with immunohistochemical
development of CD208 antigen expression in perinatal lamb lung. J
Histochem Cytochem 2006, 54(11):1247-1253.
18. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS: The
histopathology of fatal untreated human respiratory syncytial virus
infection. Mod Pathol 2007, 20(1):108-119.
19. Brandenburg AH, Neijens HJ, Osterhaus AD: Pathogenesis of RSV lower
respiratory tract infection: implications for vaccine development. Vaccine
2001, 19(20-22):2769-2782.
20. Cutlip RC, Lehmkuhl HD: Lesions in lambs experimentally infected with
bovine respiratory syncytial virus. Am J Vet Res 1979, 40(10):1479-1482.
21. Lehmkuhl HD, Cutlip RC: Experimental respiratory syncytial virus infection
in feeder-age lambs. Am J Vet Res 1979, 40(12):1729-1730.
22. Lehmkuhl HD, Cutlip RC: Experimentally induced respiratory syncytial
viral infection in lambs. Am J Vet Res 1979, 40(4):512-544.
23. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD,
Sewell HF, Milner AD: Analysis of cells obtained by bronchial lavage of infants
with respiratory syncytial virus infection. Arch Dis Child 1994, 71(5):428-432.
24. Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG, van
Vught AJ, van der Werff DB, van Gestel SJ, Semple MG, Smyth RL,
Kimpen JL, van Bleek GM: CD8+ T cell responses in bronchoalveolar
lavage fluid and peripheral blood mononuclear cells of infants with
severe primary respiratory syncytial virus infections. J Immunol 2007,
179(12):8410-8417.
25. Smith PK, Wang SZ, Dowling KD, Forsyth KD: Leucocyte populations in
respiratory syncytial virus-induced bronchiolitis. J Paediatr Child Health
2001, 37(2):146-151.
26. Klebanoff SJ: Myeloperoxidase-halide-hydrogen peroxide antibacterial
system. J Bacteriol 1968, 95(6):2131-2138.
27. Lehrer RI, Hanifin J, Cline MJ: Defective bactericidal activity in
myeloperoxidase-deficient human neutrophils. Nature 1969,
223(5201):78-79.
28. Kitahara M, Eyre HJ, Simonian Y, Atkin CL, Hasstedt SJ: Hereditary
myeloperoxidase deficiency. Blood 1981, 57(5):888-893.
29. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003,
3(1):23-35.
30. Cunningham CK, McMillan JA, Gross SJ: Rehospitalization for respiratory
illness in infants of less than 32 weeks’ gestation. Pediatrics 1991,
88(3):527-532.
31. Yuksel B, Greenough A: Birth weight and hospital readmission of infants
born prematurely. Arch Pediatr Adolesc Med 1994, 148(4):384-388.
32. Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal
system of recognition. Cell 1997, 91(3):295-298.
33. Zeng R, Li C, Li N, Wei L, Cui Y: The role of cytokines and chemokines in
severe respiratory syncytial virus infection and subsequent asthma.
Cytokine 53(1):1-7.
34. Krishnan S, Halonen M, Welliver RC: Innate immune responses in
respiratory syncytial virus infections. Viral Immunol 2004, 17(2):220-233.
35. Moore ML, Peebles RS Jr: Respiratory syncytial virus disease mechanisms
implicated by human, animal model, and in vitro data facilitate vaccine
strategies and new therapeutics. Pharmacol Ther 2006, 112(2):405-424.
36. Wright WC Jr, Ank BJ, Herbert J, Stiehm ER: Decreased bactericidal activity
of leukocytes of stressed newborn infants. Pediatrics 1975, 56(4):579-584.
37. Cairo MS: Neonatal neutrophil host defense. Prospects for immunologic
enhancement during neonatal sepsis. Am J Dis Child 1989, 143(1):40-46.
38. Carr R: Neutrophil production and function in newborn infants. Br J
Haematol 2000, 110(1):18-28.
39. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 2003,
73(2):209-212.
40. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K,
Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL,
Welliver RC Sr: Severe human lower respiratory tract illness caused by
respiratory syncytial virus and influenza virus is characterized by the
absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007,
195(8):1126-1136.
41. Braciale TJ: Respiratory syncytial virus and T cells: interplay between the
virus and the host adaptive immune system. Proc Am Thorac Soc 2005,
2(2):141-146.
42. Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L,
Huang J, Renauld JC, Kotenko SV, Roederer M, Beeler JA, Donnelly RP,
Collins PL, Rabin RL: Alpha and lambda interferon together mediate
suppression of CD4 T cells induced by respiratory syncytial virus. J Virol
2006, 80(10):5032-5040.
43. Chang J, Braciale TJ: Respiratory syncytial virus infection suppresses lung
CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the
respiratory tract. Nat Med 2002, 8(1):54-60.
44. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O’Donnell DR:
Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis.
Clin Exp Immunol 2004, 137(1):139-145.
45. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH,
Freeman GJ, Ahmed R: Restoring function in exhausted CD8 T cells
during chronic viral infection. Nature 2006, 439(7077):682-687.
46. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S,
Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J,
Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ,
Klenerman P, Ahmed R, Freeman GJ, Walker BD: PD-1 expression on HIV-
specific T cells is associated with T-cell exhaustion and disease
progression. Nature 2006, 443(7109):350-354.
47. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B,
Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK,
Sekaly RP: Upregulation of PD-1 expression on HIV-specific CD8+ T cells
leads to reversible immune dysfunction. Nat Med 2006, 12(10):1198-1202.
48. Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, Adams WC,
Precopio ML, Schacker T, Roederer M, Douek DC, Koup RA: PD-1 is a
regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med
2006, 203(10):2281-2292.
doi:10.1186/1465-9921-12-106
Cite this article as: Sow et al.: Respiratory syncytial virus infection is
associated with an altered innate immunity and a heightened pro-
inflammatory response in the lungs of preterm lambs. Respiratory
Research 2011 12:106.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sow et al. Respiratory Research 2011, 12:106
http://respiratory-research.com/content/12/1/106
Page 12 of 12